NCT06500273Phase 2Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Study sponsor: Allogene Therapeutics

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2027-12Estimated
Enrollment · participants250Estimated
Source updated2026-08-31Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date

Recorded edit
− Previous value

2027-08-24

+ Updated value

2027-12

Check registry source